摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9,10-dihydro-2,5-dimethoxyphenanthrene-1,7-diol | 118201-22-2

中文名称
——
中文别名
——
英文名称
9,10-dihydro-2,5-dimethoxyphenanthrene-1,7-diol
英文别名
2,5-Dimethoxy-9,10-dihydrophenanthrene-1,7-diol
9,10-dihydro-2,5-dimethoxyphenanthrene-1,7-diol化学式
CAS
118201-22-2
化学式
C16H16O4
mdl
——
分子量
272.301
InChiKey
YSSFIGREEVEYNI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    502.4±50.0 °C(Predicted)
  • 密度:
    1.290±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    58.9
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    9,10-dihydro-2,5-dimethoxyphenanthrene-1,7-diol 生成 (8-acetyloxy-4,7-dimethoxy-9,10-dihydrophenanthren-2-yl) acetate
    参考文献:
    名称:
    TUCHINDA, PATOOMRATANA;UDCHACHON, JINDA;KHUMTAVEEPORN, KANJAI;TAYLOR, WAL+, PHYTOCHEMISTRY, 27,(1988) N 10, C. 3267-3271
    摘要:
    DOI:
  • 作为产物:
    描述:
    2-苄氧基-3-甲氧基苯甲醛 在 sodium tetrahydroborate 、 偶氮二异丁腈 、 palladium 10% on activated carbon 、 lithium methanolate氢气三正丁基氢锡三溴化磷 作用下, 以 甲烷磺酸乙醇二氯甲烷乙酸乙酯N,N-二甲基甲酰胺异丙醇甲苯 为溶剂, 110.0 ℃ 、482.64 kPa 条件下, 反应 36.0h, 生成 9,10-dihydro-2,5-dimethoxyphenanthrene-1,7-diol
    参考文献:
    名称:
    Regioselective synthesis of phenanthrenes and evaluation of their anti-oxidant based anti-inflammatory potential
    摘要:
    Regioselective synthesis of 9,10-Dihydro-2,5-Dimethoxyphenanthrene-1,7-diol (1) and 9,10-Dihydro-2,7-Dimethoxyphenanthrene-1,5-diol (2) was achieved using regioselective methylation, Wittig reaction, intramolecular cyclization and hydrogenation as key steps. The synthesis was successfully completed in total of 15 steps with 3.3% overall yield in case of 1 and in total of 13 steps with 9.0% overall yield in case of 2. All compounds (1-4) showed good antioxidant and anti-inflammatory activity in in vitro assays and these activities were found to be due the presence of phenolic hydroxyl groups. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.06.016
点击查看最新优质反应信息

文献信息

  • Functional foods and beverages with synergistic properties to promote homeostasis
    申请人:JUSTBIO INC.
    公开号:US10028990B2
    公开(公告)日:2018-07-24
    The present invention provides compositions having synergistic antioxidant properties in the modulation of Toll-like receptor signaling for the promotion of homeostasis, immunity, energy conservation, protection of neural cells and anti-inflammatory responses, said compositions comprising plant and/or fruit extracts and a natural sweetener with high oxidation potential as defined by ORAC value.
    本发明提供了在调节 Toll 样受体信号以促进平衡、免疫、能量保存、保护神经细胞和抗炎反应方面具有协同抗氧化特性的组合物,所述组合物包括植物和/或水果提取物以及一种根据 ORAC 值定义的具有高氧化潜能的天然甜味剂。
  • FUNCTIONAL FOODS AND BEVERAGES WITH SYNERGISTIC PROPERTIES TO PROMOTE HOMEOSTASIS
    申请人:Justbio Inc.
    公开号:EP2670415A1
    公开(公告)日:2013-12-11
  • Thiazolidine Linker for the Conjugation of Drugs to Antibodies
    申请人:Philogen S.P.A.
    公开号:US20130309257A1
    公开(公告)日:2013-11-21
    In one aspect, there is provided a protein-drug conjugate compound comprising a protein covalently attached by a linker to one or more drug moieties, wherein the linker has a half-life of from 1 hour to 50 hours in phosphate buffered saline at 37° C. A carbonyl derivative of LU103793 is also described that can be used in a protein-drug conjugate compound comprising an antibody covalently attached by a linker to the drug moiety comprising, consisting or consisting essentially of the carbonyl derivative.
  • COMBINATION COMPRISING PARTHENOLIDE FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
    申请人:King Abdullah University of Science and Technology
    公开号:US20150164858A1
    公开(公告)日:2015-06-18
    The present invention generally concerns particular methods and compositions for treatment of a neurodegenerative disease, such as Alzheimer's Disease. In particular embodiments, there is a composition comprising Parthenolide and a second agent, including an inhibitor of TLR4/MD-2/CD14, nAChR agonist, Resatorvid, Curcumin, Tilorone or a Tilorone analog, or a combination thereof.
  • US9198979B2
    申请人:——
    公开号:US9198979B2
    公开(公告)日:2015-12-01
查看更多